https://www.marketsandmarkets.com/MarketsandMarkets XML Feed en-us Copyright MarketsandMarkets 12/22/2025 7:32:16 PM GMT 12/22/2025 7:32:16 PM GMT 300 https://www.marketsandmarkets.com/ MarketsandMarkets – Market Research Company publishes about 120 business market researchreports a year across 10 main industries. Market research reports and industry trends analysis available from MarketsandMarkets.12/22/2025 7:32:16 PM GMT https://www.marketsandmarkets.com/Market-Reports/compounding-pharmacy-market-57885999.htmlThe global Compounding Pharmacy market, valued at US$13.48 billion in 2024, stood at US$14.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$19.41 billion by the end of the period. ...10/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/glp-1-analogues-market-218746186.htmlThe global GLP-1 analogues market, valued at US$53.74 billion in 2024, stood at US$64.42 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2033, culminating in a forecasted valuation of US$170.75 billion by the end of the period. The market for GLP-1 agonists is highly consolidated, with key players strategizing to capture the market. Prominent players in the GLP-1 agonists market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), among other players. ...10/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/API-Market-263.htmlThe global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring....10/14/2025 GMT https://www.marketsandmarkets.com/Market-Reports/radioligand-therapy-rlt-market-238791830.htmlThe global radioligand therapy market, valued at US$2.36 billion in 2024, stood at US$3.15 billion in 2025 and is projected to advance at a resilient CAGR of 13.2% from 2025 to 2035, culminating in a forecasted valuation of US$10.91 billion by the end of the period. The growth of this market is primarily attributed to factors such as increasing approvals and label expansions of RLT products, manufacturing scale-up, particularly for Lu-177 supply, and the rising adoption of PSMA and SSTR PET imaging for patient selection....9/12/2025 GMT https://www.marketsandmarkets.com/Market-Reports/antibody-discovery-market-182887795.htmlThe global antibody discovery services market, valued at US$1.68 billion in 2024, stood at US$1.90 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2025 to 2030, culminating in a forecasted valuation of US$3.54 billion by the end of the period. Key factors driving the antibody discovery services market include the advancement of formats such as bispecific antibodies (bsAbs) and antibody-drug conjugates (ADCs), coupled with increased venture funding and collaborative initiatives....9/3/2025 GMT https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.htmlThe global vaccines market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a resilient CAGR of 4.8% from 2025 to 2030, culminating in a forecasted valuation of US$63.66 billion by the end of the period....9/2/2025 GMT https://www.marketsandmarkets.com/Market-Reports/contract-research-organization-service-market-167410116.htmlThe global contract research organization (CRO) services market, valued at US$79.10 billion in 2024, stood at US$84.61 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$125.95 billion by the end of the period. Factors such as the increasing complexity & the growing volume of trials; the rising focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs are supporting the growth of this market....9/2/2025 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-contract-manufacturing-market-201524381.htmlThe global pharmaceutical contract manufacturing market, valued at US$193.52 billion in 2024, stood at US$209.90 billion in 2025 and is projected to advance at a resilient CAGR of 8.2% from 2025 to 2030, culminating in a forecasted valuation of US$311.95 billion by the end of the period. This is mainly due to the high demand for outsourcing services for GLP-1 manufacturing, the growing ADC outsourcing for commercialized products, and the development and patent expiry of blockbuster biologics, which are paving the way for key biosimilars....8/25/2025 GMT https://www.marketsandmarkets.com/Market-Reports/targeted-protein-degradation-analysis-market-219352281.htmlThe global targeted protein degradation market, valued at US$0.01 billion in 2024, stood at US$0.48 billion in 2025 and is projected to advance at a resilient CAGR of 35.4% from 2025 to 2035, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The Asia Pacific market is projected to grow at a significant CAGR during the forecast period, owing to increasing research & development activities for novel degraders....8/19/2025 GMT https://www.marketsandmarkets.com/Market-Reports/pet-health-insurance-market-884.htmlThe global pet insurance market, valued at US$12.51 billion in 2024, stood at US$14.35 billion in 2025 and is projected to advance at a resilient CAGR of 15.7% from 2025 to 2030, culminating in a forecasted valuation of US$29.80 billion by the end of the period. This growth is mainly driven by changing consumer preferences, increasing veterinary care costs, and the growing adoption of digital technologies throughout the insurance industry. ...8/12/2025 GMT https://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.htmlThe global empty capsules market, valued at US$3.05 billion in 2024, stood at US$3.19 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$4.19 billion by the end of the period....7/25/2025 GMT https://www.marketsandmarkets.com/Market-Reports/fill-finish-manufacturing-market-6249609.htmlThe global fill finish manufacturing market, valued at US$16.85 billion in 2024, stood at US$18.36 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$28.14 billion by the end of the period. The European market is projected to grow at a significant CAGR during the forecast period, owing to strong regulatory frameworks and increasing demand for sterile injectable drugs....7/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/topical-drug-delivery-market-124871717.htmlThe global topical drug delivery market, valued at US$247.3 billion in 2024, stood at US$268.4 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$409.0 billion by the end of the period....7/9/2025 GMT https://www.marketsandmarkets.com/Market-Reports/botulinum-toxins-market-146254750.htmlThe global botulinum toxins market, valued at US$8.1 billion in 2024, stood at US$8.9 billion in 2025 and is projected to advance at a resilient CAGR of 11.7% from 2025 to 2030, culminating in a forecasted valuation of US$15.7 billion by the end of the period.The rising societal emphasis on maintaining a youthful appearance, especially within urban environments and professional contexts, is driving an increasing number of individuals to seek out cosmetic procedures, with botulinum toxins (commonly known as Botox) being among the most popular options....7/8/2025 GMT https://www.marketsandmarkets.com/Market-Reports/suppositories-market-64269069.htmlThe global suppositories market, valued at US$1.56 billion in 2024, stood at US$1.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.7% from 2025 to 2030, culminating in a forecasted valuation of US$2.05 billion by the end of the period. The growth in the suppositories market can be attributed to several critical factors. ...7/7/2025 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-metal-detector-market-133098373.htmlThe global pharmaceutical metal detectors market, valued at US$151.7 million in 2024, stood at US$157.1million in 2025 and is projected to advance at a resilient CAGR of 4.7% from 2025 to 2030, culminating in a forecasted valuation of US$197.7 million by the end of the period....7/4/2025 GMT https://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.htmlThe global pharmaceutical excipients market, valued at US$10.5 billion in 2024, stood at US$11.0 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$14.9 billion by the end of the period. Growing demand for pharmaceutical products and generic medications, along with increasing investments in research and development for innovative excipient formulations, are key drivers fueling market expansion...7/1/2025 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-equipment-market-19845828.htmlThe global pharmaceutical packaging equipment market, valued at US$9.75 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$14.3 billion by the end of the period. The pharmaceutical packaging equipment market is rapidly growing due to the increasing demand for accurate and high-quality diagnostic imaging, fueled by a rise in chronic diseases and an aging population....6/30/2025 GMT https://www.marketsandmarkets.com/Market-Reports/ophthalmology-drugs-market-132608438.htmlThe global ophthalmology drugs market, valued at US$18.34 billion in 2024, stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$26.28 billion by the end of the period....6/18/2025 GMT https://www.marketsandmarkets.com/Market-Reports/derma-fillers-market-71526267.htmlThe global derma fillers market, valued at US$3.74 billion in 2024, stood at US$4.13 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted valuation of US$ 7.32 billion by the end of the period. The key factors driving the derma fillers market are the demand for non-invasive procedures, social media celebrity influence, technological innovation and advancement, an aging population, rising disposable incomes, and increased interest in personalized treatments....6/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/biosimilars-40.htmlThe global biosimilars market, valued at US$32.75 billion in 2024, stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a forecasted valuation of US$72.29 billion by the end of the period. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options....6/6/2025 GMT https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.htmlThe global clinical trial supplies market, valued at US$4.85 billion in 2024, stood at US$5.34 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. The growing complexity of clinical trials, particularly with decentralized and adaptive trial designs, has heightened the demand for efficient supply chain management solutions....3/28/2025 GMT https://www.marketsandmarkets.com/Market-Reports/drug-discovery-services-market-138732129.htmlThe global drug discovery services market, valued at US$14.89B in 2024, is forecasted to grow at a 10.7% CAGR, reaching US$16.36B by 2025 and US$27.23B by 2030. Growing awareness about personalized medicines and targeted therapies, a vast patient population, and emerging middle-class population are enhancing market penetration in the Asia Pacific region....3/25/2025 GMT https://www.marketsandmarkets.com/Market-Reports/central-lab-services-market-106848348.htmlThe global central lab services/clinical trial lab services market, valued at US$5.64 billion in 2024, stood at US$5.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. The growth of the Asia Pacific central lab services/clinical trial lab services market can be attributed to the increasing prevalence of chronic diseases, such as cancer, kidney diseases, and CVDs....3/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/clinical-trials-market-405.htmlThe global Clinical Trial Services market, valued at US$60.76 billion in 2024, stood at US$66.59 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$101.86 billion by the end of the period. Factors such as the growing focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs) and the increasing number of clinical trials for precision/personalized medicines are supporting the growth of this market....3/11/2025 GMT https://www.marketsandmarkets.com/Market-Reports/oral-proteins-peptides-market-194705708.htmlThe global oral proteins and peptides market, valued at US$8.07 billion in 2024, stood at US$9.31 billion in 2025 and is projected to advance at a resilient CAGR of 16.4% from 2025 to 2030, culminating in a forecasted valuation of US$19.93 billion by the end of the period. This growth is driven by several factors, including the rising prevalence of chronic diseases such as diabetes, gastrointestinal disorders, and kidney diseases....2/28/2025 GMT https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.htmlThe global veterinary vaccines market, valued at US$8.93 billion in 2023, stood at US$9.39 billion in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$13.33 billion by the end of the period.. Growing awareness of animal health, along with the rising pet population and ownership, is driving the adoption of veterinary vaccines. Government efforts to improve animal health and the increasing popularity of pet insurance are also contributing to this trend....1/8/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cancer-vaccines-market-30645011.htmlThe global cancer vaccines market, valued at US$9.70 billion in 2023, stood at US$9.84 billion in 2024 and is projected to advance at a resilient CAGR of 5.4% from 2024 to 2032, culminating in a forecasted valuation of US$15.00 billion by the end of the period. The cancer vaccines market is growing rapidly, fueled by rising prevalence of cancer, technological advancements in immunotherapy, and increasing adoption of preventive healthcare across the globe. ...12/9/2024 GMT https://www.marketsandmarkets.com/Market-Reports/freeze-drying-lyophilization-equipment-market-24018886.htmlThe global pharmaceutical drying equipment market, valued at US$5.45B in 2023, is forecasted to grow at a 7.1% CAGR, reaching US$5.80B by 2024 and US$8.18B by 2029. The expansion of pharmaceutical manufacturing facilities globally, increased demand for biopharmaceuticals such as vaccines, antibodies, and hormones, and the rapid growth of CMOs drive market growth. ...10/24/2024 GMT https://www.marketsandmarkets.com/Market-Reports/halal-empty-capsules-market-166042038.htmlThe global halal empty capsules market, valued at US$1.17 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 5.4% from 2024 to 2029, culminating in a forecasted valuation of US$1.55 billion by the end of the period. The major factors contributing to the growth of this market include increased adoption of halal-certified and clean label products in emerging and developed countries and the presence of key market players providing halal empty capsules. Furthermore, the launch of new halal-certified products in the market is likely to drive market adoption in the coming years....10/11/2024 GMT https://www.marketsandmarkets.com/Market-Reports/age-related-macular-degeneration-market-37446234.htmlThe global age-related macular degeneration (AMD) drugs market, valued at US$9.55 billion in 2023, stood at US$10.46 billion in 2024 and is projected to advance at a resilient CAGR of 10.7% from 2024 to 2029, culminating in a forecasted valuation of US$17.37 billion by the end of the period. Factors such as the increase in the prevalence of AMD cases due to the changing lifestyle and dietary habits such as smoking, alcohol consumption, and lack of physical activity, a growing focus on research and development highlighted by steady development and approvals of AMD drugs along with improvements in reimbursement policies providing better and affordable access to therapeutic AMD drugs, supports the growth of this market....9/27/2024 GMT https://www.marketsandmarkets.com/Market-Reports/cleanroom-technology-market-263122482.htmlThe global cleanroom technologies market, valued at US$8.3 billion in 2023, stood at US$8.8 billion in 2024 and is projected to advance at a resilient CAGR of 6.9% from 2024 to 2029, culminating in a forecasted valuation of US$12.3 billion by the end of the period. The rising need for contamination-free environments in the pharmaceutical, medical device, and semiconductor industries drives the growth of cleanroom technologies....9/26/2024 GMT https://www.marketsandmarkets.com/Market-Reports/car-t-cell-therapy-market-47772841.htmlThe global CAR T-cell therapy market, valued at US$3.7 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 39.6% from 2024 to 2029, culminating in a forecasted valuation of US$29.0 billion by the end of the period. The growth of this market due to the rise in investments and funding for CAR T-cell therapy developments and technological advancements in CAR T-cell therapy. ...7/19/2024 GMT https://www.marketsandmarkets.com/Market-Reports/immunotherapy-drug-market-137717755.htmlThe global immunotherapy drugs market, valued at US$255.9 billion in 2023, stood at US$285.3 billion in 2024 and is projected to advance at a resilient CAGR of 15.3% from 2024 to 2029, culminating in a forecasted valuation of US$580.6 billion by the end of the period. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies....7/18/2024 GMT https://www.marketsandmarkets.com/Market-Reports/inspection-machines-market-81453085.htmlThe global pharmaceutical inspection machines market, valued at US$0.9 billion in 2023, stood at US$0.9 billion in 2024 and is projected to advance at a resilient CAGR of 7.6% from 2024 to 2029, culminating in a forecasted valuation of US$1.4 billion by the end of the period. The major factors driving the pharmaceutical inspection machines growth are increasing use of inspection machines by pharmaceutical and biotechnology companies, increasing number of inspection checkpoint mandates in pharmaceutical products, and rise in pharmaceutical outsourcing in emerging economies....7/9/2024 GMT https://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.htmlThe global autologous stem cell & non-stem cell therapies market, valued at US$3.9 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2029, culminating in a forecasted valuation of US$22.2 billion by the end of the period. The major factors driving the growth of this market are the rising regulatory approvals for autologous CAR T cell therapies, increasing R&D investments in autologous therapeutics, and growing demand for personalized medicines....6/7/2024 GMT https://www.marketsandmarkets.com/Market-Reports/monoclonal-antibody-mabs-therapeutics-market-115323820.htmlThe global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development. ...3/15/2024 GMT https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.htmlThe global theranostics market, valued at US$1.9 billion in 2022, stood at US$2.1 billion in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.3 billion by the end of the period. Increasing establishment of hospitals, rising focus on targeted therapies, and introduction of novel theranostic approaches are expected to drive the market during the forecast period....1/22/2024 GMT https://www.marketsandmarkets.com/Market-Reports/antibody-therapeutics-market-178852478.htmlThe global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others...12/4/2023 GMT https://www.marketsandmarkets.com/Market-Reports/continuous-bioprocessing-market-75067818.htmlThe global continuous bioprocessing market, valued at US$201 million in 2022, stood at US$218 million in 2023 and is projected to advance at a resilient CAGR of 22.4% from 2023 to 2028, culminating in a forecasted valuation of US$599 million by the end of the period. The growth of the market is largely driven by rising demand for biopharmaceuticals, advantages of continuous bioprocessing over batch/fed-batch mode, and emergence of integrated end-to-end continuous bioprocessing....11/22/2023 GMT https://www.marketsandmarkets.com/Market-Reports/cardiac-safety-services-market-174488627.htmlThe global Cardiac safety services market market, valued at US$665 million in 2022, stood at US$739 million in 2023 and is projected to advance at a resilient CAGR of 11.6% from 2023 to 2028, culminating in a forecasted valuation of US$1,282 million by the end of the period. Key drivers of this growth include the rising incidence of cardiovascular diseases, which boosts demand from pharmaceutical companies and CROs....10/3/2023 GMT https://www.marketsandmarkets.com/Market-Reports/softgel-capsules-market-238329912.htmlThe global softgel capsules market, valued at US$1.0 billion in 2022, stood at US$1.1 billion in 2023 and is projected to advance at a resilient CAGR of 6.3% from 2023 to 2028, culminating in a forecasted valuation of US$1.5 billion by the end of the period. The growth of this market is majorly driven by the benefits of softgel capsules, increasing demand for dietary supplements and nutraceuticals, and rising demand for naturally sourced ingredients. ...9/29/2023 GMT https://www.marketsandmarkets.com/Market-Reports/veterinary-api-market-91801752.htmlThe global veterinary API market, valued at US$8.0 billion in 2022, stood at US$8.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$11.9 billion by the end of the period. The veterinary active pharmaceutical ingredient (API) market is growing due to various factors, including the increased occurrence of transboundary and zoonotic diseases, a rise in the global animal population and pet ownership, and the implementation of improved disease control and prevention measures....6/20/2023 GMT https://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.htmlThe global nuclear medicine market, valued at US$4.9 billion in 2021, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$9.4 billion by the end of the period. The market growth in this sector is driven by factors such as advancements in radioisotope production technology and the rising prevalence of cancer and cardiovascular diseases (CVD)....5/4/2023 GMT https://www.marketsandmarkets.com/Market-Reports/animal-parasiticide-market-258895412.htmlThe global animal parasiticides market in terms of revenue was estimated to be worth $10.6 billion in 2022 and is poised to reach $14.1 billion by 2027, growing at a CAGR of 5.8% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....3/28/2023 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-gelatin-market-21807555.htmlThe global pharmaceutical gelatin market growth is primed to transition from $1.1 billion in 2022 to $1.5 billion by 2027, showcasing a strong CAGR of 5.5%. Growth of this market is attributable to various factors such as rising demand for pharma gelatin in vaccines, tablets, and other applications. Furthermore, the launch of the novel, technologically advanced, and user-friendly pharma gelatin is likely to increase global demand. ...12/5/2022 GMT https://www.marketsandmarkets.com/Market-Reports/single-use-consumable-market-44374840.htmlThe size of global single use consumables market in terms of revenue was estimated to be worth USD 2.2 billion in 2022 and is poised to reach USD 4.7 billion by 2027, growing at a CAGR of 16.6% from 2022 to 2027. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics....10/27/2022 GMT https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-formulas-market-74876393.htmlThe global enteral feeding formulas market growth is primed to transition from $5.2 billion in 2022 to $8.2 billion by 2027, showcasing a strong CAGR of 9.5%. Factors such as rising healthcare expenditure; a surge in the number of preterm births worldwide; growing aging population in need for enteral feeding; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition benefits; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period....8/5/2022 GMT https://www.marketsandmarkets.com/Market-Reports/overactive-bladder-treatment-market-219938791.htmlThe size of global overactive bladder treatment market in terms of revenue was estimated to be worth USD 3.5 billion in 2022 and is poised to reach USD 4.2 billion by 2027, growing at a CAGR of 3.6% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....7/4/2022 GMT https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market-36582475.htmlThe global high potency APIs market growth is primed to transition from $24.5 billion in 2022 to $39.6 billion by 2027, showcasing a strong CAGR of 10.1%. This growth is driven by increasing demand for oncology drugs, advancements in HPAPI manufacturing technologies, and the rising focus on precision medicine....5/17/2022 GMT